ClearPoint Neuro, Inc. CLPT

CLPT Company Overview

ClearPoint Neuro, Inc. is a U.S.-based medical technology company focused on developing and commercializing platform technologies for minimally invasive neurosurgery and precision drug delivery to the brain. The company operates within the neurosurgical navigation, neurointervention, and gene and cell therapy enablement industries. Its core offerings are designed to support MRI-guided procedures in the brain and spine, particularly for applications involving deep brain stimulation, laser ablation, biopsies, and the direct delivery of biologics such as gene therapies. The company generates revenue primarily through capital equipment sales, disposable surgical products, software platforms, service agreements, and collaborations with pharmaceutical and biotechnology companies.

The company’s principal business lines center around the ClearPoint Neuro Navigation System, related disposable devices, and therapy-enabling services for partners developing central nervous system treatments. ClearPoint Neuro serves hospitals, academic medical centers, neurosurgeons, and life sciences companies pursuing therapies for neurological disorders. The company has positioned itself as a specialized provider in MRI-guided neurosurgical intervention and intracranial drug delivery, an area with relatively few established competitors due to technical complexity, regulatory requirements, and the need for integration with advanced imaging environments. Originally founded as MRI Interventions, Inc., the company later rebranded to ClearPoint Neuro to reflect broader ambitions in precision neurosurgery and biologic delivery technologies.